Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05301348 · ClinicalTrials.gov registry record · NA
In Vivo Detection of Circulating Clots in Patients With Thromboembolism
A NA study of Thromboembolism, sponsored by University of Arkansas.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05301348: Recruiting NA study of Thromboembolism, sponsored by University of Arkansas.
NCT05301348 is a NA study of Thromboembolism that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 30 participants, below the 312-participant average among 8 other Thromboembolism trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05301348, a NA study of Thromboembolism, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
Primary Outcome
Measurement of in vivo CBC-associated positive PA peaks in a signal trace of patients who have been diagnosed with conventional methods.
Conditions Studied
Interventions
- DEVICE Photoacoustic Flow Cytometry
Study Locations (1)
Arkansas
- Univerisity of Arkansas for Medical Sciences - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-07-26 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT05301348 shows while recruiting
NCT05301348 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 312-participant average among 8 other Thromboembolism trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Thromboembolism appearing as the primary indexed condition, and to 1 intervention - of which Photoacoustic Flow Cytometry is the first listed.
NCT05301348 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05301348 about?
NCT05301348 is a clinical study titled "In Vivo Detection of Circulating Clots in Patients With Thromboembolism". Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.
What is the current status of trial NCT05301348?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-07-26. Estimated completion is 2027-01-31.
What conditions does trial NCT05301348 study?
This clinical trial studies the following conditions: Thromboembolism.
What interventions are being tested in trial NCT05301348?
The interventions under investigation include: Photoacoustic Flow Cytometry (DEVICE).
Who is sponsoring clinical trial NCT05301348?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05301348 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thromboembolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05301348's enrollment target sits among peer trials
30 8th of 8 higher than 1 of 8 other Thromboembolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thromboembolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery
COMPLETED · NA
-
Strategies for Anticoagulation During Venovenous ECMO
COMPLETED · NA
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
COMPLETED · NA
-
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
RECRUITING · Phase 2
-
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
ACTIVE NOT RECRUITING · Phase 4
-
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI